1.Challenges in the conduct of clinical research
Yasuji ARIMURA ; Toshihiko NISHIDA ; Maya MINAMI ; Yoko YOKOYAMA ; Hiroki MISHINA ; Shin YAMAZAKI ; Tatsuro ISHIZAKI ; Koji KAWAKAMI ; Takeo NAKAYAMA ; Yuichi IMANAKA ; Takashi KAWAMURA ; Shunichi FUKUHARA
Medical Education 2010;41(4):259-265
The promotion of clinical research in Japan requires the establishment of a formal and systematic education and training program for clinicians to ensure they become effective clinician investigators. The first of its kind in Japan, a formal 1-year masters-degree-level training program (MCR course) was started at Kyoto University School of Medicine and Public Health. The first 28 students graduated in 2008, with most returning to their original clinical institutions.
1) As follow-up, we conducted a self-administered questionnaire survey of all 28 graduates (response rate, 86%) concerning the current status of clinical research and problems encountered at their institutions.
2) Almost 40% of respondents (n=24) reported "no time" or "no research collaborators" for clinical research.
3) Twenty respondents (83%) have attempted to promote clinical research at their hospital or workplace, but only 1 has received institutional support.
4) Over half of the respondents (54%) would like to be working in both clinical research and clinical practice at their hospital in the future (10-year timescale). Forty-two percent of respondents had a concrete image of the clinical researcher's career path.
5) Although open to improvement, the MCR program presents a concrete model for the education of clinical researchers. These findings suggest that promoting the conduct of clinical research requires the implementation of a support system and adjustment of personal and physical infrastructure.
2.Body composition changes following chemotherapy for testicular germ cell tumor: obesity is the long-term problem.
Yuki TAKAI ; Sei NAITO ; Hidenori KANNO ; Atsushi YAMAGISHI ; Mayu YAGI ; Toshihiko SAKURAI ; Hayato NISHIDA ; Takuya YAMANOBE ; Tomoyuki KATO ; Norihiko TSUCHIYA
Asian Journal of Andrology 2022;24(5):458-462
Metabolic syndrome is a long-term complication of systemic chemotherapy for testicular germ cell tumor (TGCT). It is believed to be caused by secondary hypogonadism or toxic medicines because of orchidectomy followed by systemic chemotherapy. In this study, changes in the body composition of patients over time were quantitatively analyzed up to 24 months after chemotherapy. This study retrospectively analyzed 44 patients with TGCT who underwent chemotherapy at our institution from January 2008 to December 2016. Subcutaneous and visceral fat areas and psoas and skeletal muscle areas were measured by computed tomography before and immediately after chemotherapy as well as 3 months, 6 months, 12 months, and 24 months after chemotherapy. The subcutaneous and visceral fat indices and psoas and skeletal muscle indices were calculated as each area divided by body height squared. The total fat area had already significantly increased 3 months after the initiation of chemotherapy (P = 0.004). However, it did not return to prechemotherapeutic levels even at 24 months after chemotherapy. The skeletal muscle area was significantly decreased at the end of chemotherapy (P < 0.001); however, the value returned to baseline within 12 months. In multivariable analysis, the prechemotherapeutic skeletal muscle index and number of chemotherapy cycles were independently associated with the reduction of skeletal muscle at the end of chemotherapy (P = 0.001 and P = 0.027, respectively). In patients with TGCT, skeletal muscle mass decreased during chemotherapy and recovered within 12 months, whereas fat mass progressively increased from the initiation of chemotherapy until 24 months after chemotherapy.
Body Composition
;
Body Mass Index
;
Humans
;
Male
;
Muscle, Skeletal
;
Neoplasms, Germ Cell and Embryonal
;
Obesity
;
Retrospective Studies
;
Sarcopenia
;
Testicular Neoplasms